Showing 1 - 20 results of 3,624 for search '(( using ((stat decrease) OR (small decrease)) ) OR ( i ((larger decrease) OR (marked decrease)) ))', query time: 0.87s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Withdrawal of Type I JAKinibs increased STAT phosphorylation, a phenomenon present but markedly lower in Type II JAKinibs. by Ilya Gurevic (1326786)

    Published 2025
    “…(A) pJAK2 peaked at time zero after exposure to baricitinib and ruxolitinib and then decreases. There was no increase in pJAK2 with CHZ868 treatment; (B) pSTAT1 proportion peaked after 60 minutes and was greater after Type I JAKinib withdrawal than Type II JAKinib withdrawal; <b>(C)</b> The pSTAT2 proportion peaked 60 minutes after Type I JAKinib withdrawal but this phenomenon was not seen with Type II JAKinib withdrawal.…”
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Improving QoL through the use of STAT-ON™. by Daniel Rodriguez-Martin (22411006)

    Published 2025
    “…While medication costs may increase, overall direct healthcare expenses decrease, leading to net savings. As an example, the study estimates potential cost reductions of up to €137.8 million in Germany and €19 million in Sweden when STAT-ON™ is used to detect advanced PD symptoms. …”
  19. 19
  20. 20

    S1 File - by Hongyu Li (1332669)

    Published 2025
    “…Following the overexpression of miRNA 221 in myocardium, there was a marked alleviation of myocardial injury and cardiomyocyte apoptosis and necrosis, significant enhancement of left ventricular systolic function, and marked decrease in the levels of PLB, p-PLB (Ser16), p-PLB (Thr17), caspase 3 and Cyt C, as well as a significant decrease in total calcium levels in myocardium.…”